Amyloid precursor protein binding protein Fe65 is cleaved by caspases during DNA damage-induced apoptosis

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 2, 2011, Pages 290-294

  Saeki, Kazunori ^a   Nose, Yasuyo ^a   Hirao, Nobukuni ^a   Takasawa, Ryoko ^a   Tanuma, Sei Ichi ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Apoptosis; Caspase; DNA damage; Fe65

Indexed keywords

AMYLOID BETA PROTEIN; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CAMPTOTHECIN; CASPASE 3; CASPASE 9; ETOPOSIDE; PROTEIN FE65;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; APOPTOSIS; CAMPTOTHECIN; CASPASES; CELL LINE, TUMOR; CYTOTOXINS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ETOPOSIDE; HUMANS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEURONS; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION;

EID: 79551472984     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.290     Document Type: Article

References (24)

1. Alnemri E. S., Livingston D. J., Nicholson D. W., Salvesen G., Thomberry N. A., Wong W. W., Yuan J., Cell, 87, 171 (1996).
2. Kaufmann S. H., Desnoyers S., Ottaviano Y., Davidson N. E., Poirier G. G., Cancer Res., 53, 3976-3985 (1993).
3. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S., Nature (London), 391, 43-50 (1998).
4. Li H., Zhu H., Xu C. J., Yuan J., Cell, 94, 491-501 (1998).
5. Okita N., Kudo Y., Tanuma S., Biol. Pharm. Bull., 30, 359-362 (2007).
6. Esposito F., Ammendola R., Duilio A., Costanzo F., Giordano M., Zambrano N., Dagostino P., Russo T., Cimino F., Dev. Neurosci., 12, 373-381 (1990).
7. Duilio A., Faraonio R., Minopoli G., Zambrano N., Russo T., Biochem. J., 330, 513-519 (1998).
8. McLoughlin D. M., Miller C. C., J. Neurosci. Res., 86, 744-754 (2008).
9. Ando K., Iijima K., Elliott J. I., Kirino Y., Suzuki T., J. Biol. Chem., 276, 40353-40361 (2001).
10. Sabo S. L., Lanier L. M., Ikin A. F., Khorkova O., Sahasrabudhe S., Greengard P., Buxbaum J. D., J. Biol. Chem., 274, 7952-7957 (1999).
11. Santiard-Baron D., Langui D., Delehedde M., Delatour B., Schombert B., Touchet N., Tremp G., Paul M. F., Blanchard V., Sergeant N., Delacourte A., Duyckaerts C., Pradier L., Mercken L., J. Neurochem., 93, 330-338 (2005).
12. Lovestone S., McLoughlin D. M., J. Neurol. Neurosurg. Psychiatr., 72, 152-161 (2002).
13. Reinhard C., Hebert S. S., De Strooper B., EMBO J., 24, 3996-4006 (2005).
14. Hardy J., Neuron, 52, 3-13 (2006).
15. Fabio C., Lucia M., Curr. Alzheimer Res., 6, 36-47 (2009).
16. Mecocci P., MacGarvey U., Beal M. F., Ann. Neurol., 36, 747-751 (1994).
17. Gabbita S. P., Lovell M. A., Markesbery W. R., J. Neurochem., 71, 2034-2040 (1998).
18. Jin S. M., Cho H. J., Jung E. S., Shim M.-Y., Mock-Jung I., Cell Death Differ., 15, 1375-1384 (2008).
19. Galli C., Piccini A., Ciotti M. T., Castellani L., Calissano P., Zaccheo D., Tabaton M., Proc. Natl. Acad. Sci. U.S.A., 95, 1247-1252 (1998).
20. Shiokawa D., Tanuma S., Biochemistry, 40, 143-152 (2001).
21. Hass M. R., Yankner B. A., J. Biol. Chem., 280, 36895-36904 (2005).
22. Debatin K. M., Krammer P. H., Oncogene, 23, 2950-2966 (2004).
23. Zou H., Li Y., Liu X., Wang X., J. Biol. Chem., 274, 11549-11556 (1999).
24. Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T., Yu V. L., Miller D. K., Nature (London), 376, 37-43 (1995).